Drug
Sparc1401 Low Dose
Sparc1401 Low Dose: highest development phase Phase 2, developed by Sun Pharma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Sun Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| SPARC1401-low dose NCT02887534 | Phase 2 | Acute Muscle Pain |
Latest
No recent events.
Follow Sparc1401 Low Dose on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.